Velsecorat

Small moleculeexperimental

Clinical trial activity

10 trials · 9 clinical orgs · 0 marketing orgs

Phase 1
8
Phase 2
2
Phase 3
0
Phase 4
0

Earliest trial started Sep 1, 2012 (NCT01636024)

Timeline

2010s

  1. Jan 1, 2012

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2015

    Earliest Phase 2 Sponsor(trial)

Indications

Mechanism of action

Chemistry & pharmacology

Loading structure…

SMILES

C[C@H](NC(=O)C(C)(F)F)[C@H](Oc1ccc2c(cnn2-c2cccc(C(=O)N[C@@H]3CCOC3)c2)c1)c1ccc2c(c1)OCCO2
Mol. weight
606.63 g/mol
Lipinski Ro5
1 violation(s)
Rule of 3
No
Chirality
Single Stereoisomer
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • azd7594
  • azd7594

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT04072562Phase 1Sep 5, 2019AstraZeneca, Parexel
NCT03976869Phase 1Jul 22, 2019AstraZeneca, Parexel
NCT04002427Phase 1Jun 11, 2019AstraZeneca, Quotient
NCT03622112Phase 2Oct 12, 2018AstraZeneca, Parexel
NCT02928354Phase 1Nov 25, 2016AstraZeneca, Parexel
NCT02967159Phase 1Nov 24, 2016AstraZeneca, Parexel
NCT02648438Phase 1Jan 12, 2016AstraZeneca, Parexel
NCT02645253Phase 1Jan 1, 2016AstraZeneca, California Clinical Trials
NCT02479412Phase 2Jun 1, 2015AstraZeneca, Clinical Research Hamburg GmbH, Comac Medical, IKF Pneumologie GmbH, Frankfurt, Germany, Insaf GmbH, Wiesbaden, Germany, Parexel, University of Bonn
NCT01636024Phase 1Sep 1, 2012AstraZeneca
Showing 10 of 10 trials
Page 1 / 1

Organizations

Research & Development (9)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
AstraZenecaFor profit101022012
ParexelFor profit7022015
California Clinical TrialsFor profit1012016
Clinical Research Hamburg GmbHFor profit1012015
Comac MedicalFor profit1012015
IKF Pneumologie GmbH, Frankfurt, GermanyAcademic/Hospital1012015
Insaf GmbH, Wiesbaden, GermanyAcademic/Hospital1012015
QuotientFor profit1012019
University of BonnAcademic/Hospital1012015
9 organizations
Page 1 / 1